Skip to main content
SpringerLink
Log in

Pharmacology of penile erection in humans

  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

The pharmacologic aspects of erection, including neuropharmacology and erectile responses to exogenous agents, are reviewed. The pharmacology of erection is complex and still incompletely understood. Older evidence suggesting acetylcholine as the primary neurotransmitter has been shown to be insufficient. Our recent experiments utilizing strips of human corpus cavernosum indicate the need to consider the roles of other erectogenic substances, such as vasoactive intestinal polypeptide, endothelium-derived relaxation factor (EDRF), and prostaglandins. From the results of these studies, three stages in the development of an erection are postulated: (1) withdrawal of alpha-adrenergic neuromuscular activity, (2) inhibition of alpha-adrenergic activity by endogenous substances such as prostaglandin E1 and vasoactive intestinal polypeptide, and (3) activation of NANC neurotransmission and direct relaxation of smooth muscle by endogenous substances such as EDRF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adaikan PG, Karim SMM, Kottegoda SR, Ratnam SS (1983) Cholinoceptors in the corpus cavernosum of the human penis. J Auton Pharmacol 3:107–111

    PubMed  CAS  Google Scholar 

  2. Adaikan PG, Karim SMM (1981) Adrenoceptors in the human penis. J Auton Pharmacol 1:199–203

    PubMed  CAS  Google Scholar 

  3. Adaikan PG, Karim SMM (1978) Effect of electrical stimulation and drugs on the smooth muscle of the human penis (Abstract 1228) 7th Int Congress of Pharmacology, Paris

  4. Adaikan PG (1979) Pharmacology of the human penis, MSc Thesis, University of Singapore, Singapore, pp. 1–213

    Google Scholar 

  5. Adaikan PG, Karim SMM (1977) Effect of histamine on human penis muscle in vitro. Eur J Pharmacol 45:261–265

    Article  PubMed  CAS  Google Scholar 

  6. Adaikan PG, Kottegoda SR, Ratnam SS (1986) Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection? J Urol 135:638–640

    PubMed  CAS  Google Scholar 

  7. Brindley GS (1983) Cavernosal alpha-blockade: A new technique for investigating and treating erectile impotence. Br J Psychiatr 143:332–337

    Article  CAS  Google Scholar 

  8. Adaikan PG, Karim SMM, Kottegoda SR, Ratnam SS (1986) Adrenergic mechanisms in penile enlargement. Asia Pacific J Pharmacol 1:143–146

    Google Scholar 

  9. Domer FR, Wessler G, Brown RL, Charles HC (1978) Involvement of the sympathetic nervous system in the urinary bladder sphincter and in penile erection in the anesthetized cat. Invest Urol 15:404–407

    PubMed  CAS  Google Scholar 

  10. Zorgniotti AW, Lefleur RS (1985) Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol 133:39–41

    PubMed  CAS  Google Scholar 

  11. Gasser TC, Roach RM, Larsen EH, Madsen PO, Bruskewitz RC (1987) Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol 137:678–680

    PubMed  CAS  Google Scholar 

  12. Adaikan PG, Lau LC, Ratnam SS (1987) Inactivation of noradrenergic activity in the penis is essential for erectile process in man. Proc 1st Asia Pacific Soc for Impotence Res Meeting, 5–6 Nov 1987, Hong Kong, p 11, Abs 5

  13. Abber JC, Lue TF, Luo J, Juenemann K, Tanagho EA (1987) Priapism induced by chlorpromazine and trazodone: Mechanism of action. J Urol 137:1039–1042

    PubMed  CAS  Google Scholar 

  14. Adaikan PG (in press) Pharmacology of the human penis and drug treatment for impotence. JR Prous Publishing

  15. Sunagane N, Fujihara R, Uruno T, Kubuta K (1984) Mechanisms of relaxant action of papaverine IV. Roles of sodium ion and cyclic AMP. J Pharmacol 35:461–464

    CAS  Google Scholar 

  16. Virag R (1982) Intracavernous injection of papaverine for erectile failure. Lancet 11:938

    Article  Google Scholar 

  17. Adaikan PG, Ratnam SS (1987) Neurotransmitter (s) in human penile erection: The status of noradrenalin, vasoactive intestinal polypeptide and prostaglandins. Rev Bras De Angiol E Cir Vasc 17:100–108

    Google Scholar 

  18. Adaikan PG, Kottegoda SR, Ratnam SS (1986) A possible role for prostaglandin E1 in human penile erection (Abstract 2.6) 2nd World Meeting on Impotence, Prague

  19. Virag R, Adaikan PG (1987) Effects of prostaglandin E1 on penile erection and erectile failure. J Urol 137:1010

    PubMed  CAS  Google Scholar 

  20. Willis E, Ottesen B, Wagner G, Sandler F, Fahrenkrug J (1981) Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand 113:545–547

    PubMed  CAS  Google Scholar 

  21. Polak J, Gu J, Mina S, Bloom SR (1981) VIP-ergic nerves of the penis. Lancet 11:217–219

    Article  Google Scholar 

  22. Ottesen B, Wagner G, Virag R, Fahrenkrug J (1984) Penile erection: A possible role for vasoactive intestinal polypeptide as a neurotransmitter. Br Med J 1:9–11

    Article  Google Scholar 

  23. Adaikan PG, Kottegoda SR, Ratnam SS (1984) Action of VIP on human penis (Abstract 467) 9th Int Cong Pharmacology, London

  24. Wagner G, Gerstenberg T (1987) Vasoactive intestinal polypeptide (Abstract) 8th World Cong Sexology, Heidelberg p 134

  25. Furchgott RF (1983) Role of endothelium in responses of vascular smooth muscle. Circ Res 53:557–573

    PubMed  CAS  Google Scholar 

  26. Vane JR, Greglewski RJ, Botting RM (1987) The endothelial cell as a metabolic and endocrine organ. TIPS 8:491–496

    CAS  Google Scholar 

  27. Peach MJ, Singer HA, Loeb AL (1985) Mechanisms of endothelium-dependent vascular smooth muscle relaxation. Biochem Pharmacol 34:1867–1874

    Article  PubMed  CAS  Google Scholar 

  28. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, National University of Singapore, National University Hospital, 5 Lower Kent Ridge Rd., 0511, Singapore

    P. Ganesan Adaikan Ph.D. & Shan S. Ratnam

Authors
  1. P. Ganesan Adaikan Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shan S. Ratnam
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adaikan, P.G., Ratnam, S.S. Pharmacology of penile erection in humans. Cardiovasc Intervent Radiol 11, 191–194 (1988). https://doi.org/10.1007/BF02577003

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02577003

Key words

Search

Navigation